Inceptua Group and Cycle Pharmaceuticals partner for a Free Goods Programme for patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU).
January 18, 2024
January 18, 2024
December 16, 2020
September 28, 2020
September 3, 2019
March 10, 2026
Foundational synthesis technology enables scalable modified 100-400nt RNA constructs, speeding design cycles and improving genome-editing precision Ci...
February 25, 2026
Epigenica today announces the launch of EpiFinder™ cNUC, a truly unique product for liquid biopsies that significantly expands the capabilities of epi...
February 23, 2026
Inceptua Group, a leading global provider of clinical trial services and supplies, and early access programs, announces the appointment of Kurt J. Hil...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225